(Those who did not respond well to azithromycin did not.) Fibromyalgia and Chronic Pain A metareview of 18 metabolomics studies suggested that altered acetylcarnitine metabolites may play a role in chronic pain A 102-person, double-blinded , 2007 Italian fibromyalgia study found that 2 capsules/day of 500 mg of acetyl-L-carnitine (LAC) plus one intramuscular (i.m.) injection of 500 mg LAC for the first 2 weeks, plus 3 500 mg capsules daily for the next 8 weeks resulted in significant improvements in visual analogue pain scores for both the treated and the placebo group
33793386, PMID 1464372
Water, Ethylhexyl Palmitate, Glycereth-26, Glycerin, Cetearyl Alcohol, Niacinamide, Hydrogenated Poly(C6-14 Olefin), Beeswax, Caprylic/Capric Triglyceride, Polyglyceryl-2 Stearate, Dipropylene Glycol, Isododecane, Glyceryl Stearate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Stearyl Alcohol, Glycol Stearate SE, Sodium Polyacrylate, Hydroxyacetophenone, Stearic Acid, Dimethiconol, Dimethicone/Vinyl Dimethicone Crosspolymer, Hydrogenated Polydecene, Hydrogenated Lecithin, Tranexamic Acid, Betaine, Glutathione, Panthenol, Fragrance, Hippophae Rhamnoides Fruit Oil, Butylene Glycol, Adenosine, Sorbitan Isostearate, Caprylyl Glycol, Trideceth-6, 1,2-Hexanediol, Disodium EDTA, Sodium Hyaluronate, Ascorbic Acid Discussion Be the first who will post an article to this item
10.1056/NEJMoa2404881 64 MarsoS